Help! Please Register



  Mycoses

  Introduction
  Human
  Veterinary
  Environmental
   Industrial
  Agricultural
  MSG


  The Fungi

  Introduction
  Descriptions
  Synonyms
  Image Bank
  Lecture Bank
  Video Bank


  Drugs

  Introduction
  Medical
  Veterinary
  Environmental
   Industrial
  Agricultural


  Laboratory

  Introduction
  Susceptibility
  MIC Database
  Procedures
  Histopathology


  Education &
  Tools

  Introduction
  Abbreviations
  Links
  CME
  Conference
   Highlights
  Bibliography
  Glossary
  Good Books
  Events Calendar


  About Us

  Introduction
  Our Mission
  Editorial Board
  Editorial Staff
  Supporters
  Contributors
  Legal Stuff
  Privacy Policy
  Kudos


  The Fungi

  Introduction
  Descriptions
  Synonyms
  Image Bank
  Lecture Bank
  Video Bank



This page updated:
1/27/2007 9:23:00 AM


DoctorFungus - All Rights Reserved © 2007 Copyright
& Privacy Policy


Site built and designed for doctorfungus by Webillustrated





Knowledgebase    Knowledgebase


Q & A


  Knowledgebase Index Next Q & A
Q. Year Uploaded: 2004

With regard to Minimal Inhibitory Concentration (MIC) measurements for fungi, what is generally considered the cutoff between "susceptible" and "resistant?" What do specific numbers actually mean?

A. MIC values by themselves have no meaning. One must know which organism is being tested and against what drug. For organisms with no defined endpoints (and there are many), one would like to see a drug level concentration above the MIC.

Standardized susceptibility testing for selected organism-drug combinations has demonstrated that correlations between MIC and clinical outcome do exist, especially with the Candida species and the azole antifungal agents (REF: REX).

For mould, susceptibility testing has been standardized but clinical correlation is limited (REF: ANNA ESP). Antifungal susceptibility testing is now increasingly and appropriately used as a routine adjunct to the treatment of serious fungal infections.

For MICs of various antifungal drugs for a variety of fungi, see our susceptibility database.

*
Reference: Rex JH, Pfaller MA. Has antifungal susceptibility testing come of age? Clin Infect Dis. 2002 Oct 15;35(8):982-9. Epub 2002 Sep 24

Rex JH, Pfaller MA, Galgiani JN, Bartlett MS, Espinel-Ingroff A, Ghannoum MA, Lancaster M, Odds FC, Rinaldi MG, Walsh TJ, Barry AL. Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and Candida infections. Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Laboratory Standards. Clin Infect Dis. 1997 Feb;24(2):235-47.


Related Terms:  Laboratory
Keywords: MIC, susceptibility testing, blah,blah, blah,...

  Knowledgebase Index Next Q & A






  Home | Image Bank | Lecture Bank | Knowledgebase | Site Map | Contact Us |
The Fungi | Mycoses | Drugs |
Laboratory | Education & Tools | About Us

  bttm_banner_indv2_02[1].gif